ARTICLE | Company News
Senexis, The Wellcome Trust neurology news
May 31, 2010 7:00 AM UTC
Senexis received the final tranche of a £2.9 million ($4.2 million) award from the Wellcome Trust's Seeding Drug Discovery initiative to further develop preclinical compounds that inhibit amyloid-indu...